EMGALITY

This brand name is authorized in Austria, Australia, Brazil, Canada, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, New Zealand, Poland, Romania, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug EMGALITY contains one active pharmaceutical ingredient (API):

1 Galcanezumab UNII 55KHL3P693 - GALCANEZUMAB

Galcanezumab is a humanised IgG4 monoclonal antibody that binds calcitonin gene-related peptide (CGRP) thus preventing its biological activity. Elevated blood concentrations of CGRP have been associated with migraine attacks. Read about Galcanezumab

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
EMGALITY Solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N02CD02		N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CD Calcitonin gene-related peptide (CGRP) antagonists
Discover more medicines within N02CD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 12469G, 12478R
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 507620030020707, 507620040020807, 507620040020907, 507620040021007, 507620040021107, 507620040021207, 507620040021307
Country: CA	Health Products and Food Branch	Identifier(s): 02491060, 02491087, 02505134
Country: EE	Ravimiamet	Identifier(s): 1782918, 1782929, 1808513, 1819065, 1819076, 1819087
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1181330001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 468840
Country: FR	Base de données publique des médicaments	Identifier(s): 69972332
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 374998
Country: HK	Department of Health Drug Office	Identifier(s): 66579, 66580
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8741
Country: JP	医薬品医療機器総合機構	Identifier(s): 1190404G1020, 1190404G2026
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1086592, 1086593, 1086594, 1086595, 1087097, 1087098
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 20981, 20982
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100413118
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67371001, W67371002, W67371005
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699673954714, 8699673954721, 8699673954738, 8699673954851
Country: US	FDA, National Drug Code	Identifier(s): 0002-1436, 0002-2377, 0002-3115
Country: ZA	Health Products Regulatory Authority	Identifier(s): 54/30.1/0062